Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures
SAN JOSE, Calif., June 6, 2025 /PRNewswire/ — LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia.
LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites.
Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK’s probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance.
The company’s innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices.
These three newly granted patents underscore LEADOPTIK’s leadership in medical imaging:
- U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK’s approach.
- European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications.
“Building robust and scalable medical devices is non-negotiable,” said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. “Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected.”
“Our intellectual property is the foundation of LEADOPTIK’s competitive edge,” said Dr. Jiang You, Co-Founder and VP of Medical Imaging. “These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It’s a major milestone that strengthens our ability to scale globally and expand into new clinical applications.”
About LEADOPTIK
LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond.
For more information, visit www.leadoptik.com.
Media Contact:
[email protected]
SOURCE LEADOPTIK
